Parallel Industries Stock

Parallel Industries ROE

The Return on Equity (ROE) of Parallel Industries (EAPH) as of Aug 7, 2026 is -2.73 %. In the previous year, Return on Equity (ROE) was -4.55 % — a change of -40.07% (higher).

ROE

-2.73 %

YoY

-40.07%

Last updated:

In 2026, Parallel Industries's return on equity (ROE) was -2.73 %, a -40.07% increase from the -4.55 % ROE in the previous year.

Access this data via the Eulerpool API

Parallel Industries Stock analysis

What does Parallel Industries do? Easton Pharmaceuticals Inc. is a Canada-based company specializing in the healthcare sector and alternative medicines. It was founded in 1997 and has been listed on the Canadian Securities Exchange since 2014. The company distributes its products in the United States, Canada, Mexico, Europe, and Asia, offering a wide range of products and services including medications, medical devices, cosmetics, supplements, and agricultural products. It operates in various sectors such as the pharmaceutical industry, cosmetics industry, agricultural industry, and medical devices industry. The main business areas of the company are pharmaceuticals and cosmetic products, offering medications for neuropathic pain, chronic fatigue pain, arthritis, as well as cosmetic products with organic ingredients tailored to specific skin needs. Easton Pharmaceuticals also has a presence in the agricultural market, providing fertilizers and pesticides to promote plant growth and increase crop yields. Additionally, the company offers medical devices such as wound dressings, splints, and bandages for injury treatment. It has also invested in real estate for the development of large shopping centers and hotels. The company's business model focuses on providing products and services specifically tailored to the needs of individuals preferring alternative medicines and beauty products. Easton Pharmaceuticals continually strives to expand its brands and introduce new products to the market, while collaborating with other companies to find innovative solutions to medical and health-related problems. In 2020, Easton Pharmaceuticals entered the cannabis sector by signing an agreement with a Canadian company for hemp seed production and marketing. Overall, Easton Pharmaceuticals is a multi-sector company aiming to offer products and services tailored to specific individuals' needs, with a reputation in the industry and a commitment to expanding its presence in the future. Parallel Industries is one of the most popular companies on Eulerpool.

ROE Details

Decoding Parallel Industries's Return on Equity (ROE)

Parallel Industries's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Parallel Industries's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Parallel Industries's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Parallel Industries’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Parallel Industries stock

Return on Equity (ROE) of Parallel Industries is -2.73 % in 2026.

Return on Equity (ROE) of Parallel Industries changed from -4.55 % to -2.73 %, representing a -40.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Parallel Industries since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Parallel Industries with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Parallel Industries

All Key Metrics — Parallel Industries